ANNAPOLIS, MD (February 24, 2016) – Baltimore City Health Commissioner Dr. Leana Wen testified Wednesday before the Maryland Senate Finance Committee urging the General Assembly to support Senate Bill 382, legislation that revises Maryland’s Prescription Drug Monitoring Program (PDMP), and offered amendments to the bill that would encourage physicians to co-prescribe naloxone with opioid medications and to caution against concurrent prescribing of opioids and benzodiazepines.